Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Buy
90,995
+9,323
+11% +$1.09M 0.14% 223
2026
Q1
$9.82M Sell
81,672
-15,660
-16% -$1.81M 0.15% 207
2025
Q4
$10.2M Buy
97,332
+8,617
+10% +$809K 0.16% 186
2025
Q3
$7.45M Buy
88,715
+968
+1% +$79.7K 0.12% 278
2025
Q2
$6.95M Buy
+87,747
New +$6.97M 0.15% 228
2024
Q3
– Sell
-2,628
Closed -$325K – 1431
2024
Q2
$325K Buy
+2,628
New +$339K 0.01% 1095
2024
Q1
– Sell
-4,928
Closed -$537K – 1198
2023
Q4
$537K Buy
4,928
+517
+12% +$53.7K 0.02% 805
2023
Q3
$454K Buy
+4,411
New +$475K 0.02% 774
2023
Q1
– Sell
-2,483
Closed -$275K – 1246
2022
Q4
$275K Sell
2,483
-18,218
-88% -$1.86M 0.02% 948
2022
Q3
$1.78M Buy
20,701
+1,145
+6% +$102K 0.11% 308
2022
Q2
$1.78M Buy
+19,556
New +$1.73M 0.13% 230
2019
Q3
– Sell
-4,298
Closed -$344K – 412
2019
Q2
$344K Buy
+4,298
New +$329K 0.13% 207

Other funds holding MRK

Algert Global's MRK Position: Q2 2026 in Review

Algert Global increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $1.09M and bringing the position to 90,995 shares worth $11.7M. The position accounts for 0.14% of the portfolio, ranked #223.

Algert Global first reported a position in MRK in Q2 2019 and has held it in 12 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Algert Global held 90,995 shares of Merck worth $11.7M as of Q2 2026.
  • Algert Global bought 9,323 Merck shares in Q2 2026, an estimated $1.09M.
  • Merck made up 0.14% of Algert Global's portfolio in Q2 2026, its #223 holding.
  • Algert Global first reported a position in Merck in Q2 2019 and has held it in 12 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.